Methyl Ester of Avenanthramide‐c Inhibits TNFα‐ and IL‐1β‐induced NF‐κB Activation in Endothelial Cells

Weimin Guo,Mitchell L Wise,David M Peterson,Mohsen Meydani
DOI: https://doi.org/10.1096/fasebj.20.5.a1000-b
2006-01-01
The FASEB Journal
Abstract:Atherosclerosis is a chronic inflammatory disease accompanied by the expression of endothelial proinflammatory molecules. Avenanthramides (Avn) are polyphenols which are present exclusively in oats. We have reported the avenanthramide-enriched mixture extracted from oats significantly suppressed interleukin (IL)-1βstimulated secretion of proinflammatory cytokines IL-6, IL-8 and monocyte chemoattractant protein (MCP)-1 in human aortic endothelial cell (HAEC). Here we report that these effects could be mediated by Avn interference with the nuclear factor κB (NF-κB) dependent transcription. We used synthetically prepared methyl ester of Avn-c (CH3-Avn-c), which shows a higher potency than non-methylated form, to examine its effect on IL-1β and TNFαstimulated NF-κB activation as assessed with NF-κB DNA binding assay as well as NF-κB luciferase reporter assay. CH3-Avn-c significantly and dose-dependently decreased IL-6, IL-8 and MCP-1 secretion in human vascular endothelial cells as determined by ELISA and inhibited IL-1β and TNFαstimulated NF-κB activation as determined in NF-κB DNA binding assay and NF-κB luciferase reporter assay. However, the proteasome activity was only mildly inhibited by CH3-Avn-c. These results suggest that the CH3-Avn-c decreased expression of endothelial proinflammatory cytokines at least partially through inhibiting NF-κB activation, likely by inhibiting an upstream signaling component. Supported by USDA agreement No. 58-1950-9-001.
What problem does this paper attempt to address?